All News about Novavax Inc
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7608.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/28/hepatitis-b-virus-gd2a946894_1920.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1903418596-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1903418596-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2020/05/winners-losers.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/25/entrepreneur-1340649_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/22/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/20/aapharma_9.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2016/11/27/21/42/stock-1863880__340.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/22/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/nvax_novavax1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/04/22/covid-19_vaccine__image_by_torstensimon_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/22/hepatitis-b-virus-gd2a946894_1920.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/covid-19_vaccine__image_by_torstensimon_from_pixabay.jpg?width=1200&height=800&fit=crop)
Novavax's COVID-19 Vaccine Approved In Switzerland
April 13, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/04/nvax_novavax_2_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1874745589.png)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_866.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/50380435692_36f001b006_k.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/19/covid-gerd_alt.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/18/covid-19_vaccine_photo_by_daniel_schludi_on_unsplash.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1874745589.png)
![](https://cdn.benzinga.com/files/images/story/2022/04/18/covid-19_vaccine_1_image_by_torstensimon_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1903418596-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1909869547.png)
![](https://investorplace.com/wp-content/uploads/2020/03/nvax-stock-1.jpg)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-covidshot-01-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/nvax_novavax_2_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/04/nvax_novavax_2_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1874745589.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.